相互作用
Idecabtagene vicleucel + Interferon beta 1b
重症度: 重大
Idecabtagene vicleucel and Interferon beta 1b: major interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Idecabtagene vicleucel is a CAR-T cell therapy that causes prolonged cytopenias and immune compromise. Interferon beta may add to immune and marrow effects and could influence CAR-T cell activity. The combined effect on infection risk and efficacy is not well characterized.
この相互作用をわかりやすく説明すると
Idecabtagene vicleucel and Interferon beta 1b can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Idecabtagene vicleucel belongs to Oncology; Interferon beta 1b belongs to Central Nervous System.
なぜ起こるのか
Additive immunosuppressive and myelosuppressive effects; the effect of interferon on CAR-T expansion is not established.
対処法
Avoid interferon beta around CAR-T infusion and consider alternative multiple sclerosis therapy. If it cannot be avoided, monitor blood counts and infection signs closely.
薬剤師に尋ねること
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Idecabtagene vicleucelとInterferon beta 1bの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を14日間無料でお試し。カード登録不要。
Interferon beta 1bのその他の相互作用
Idecabtagene vicleucelのその他の相互作用
よくある質問
Can I take Idecabtagene vicleucel with Interferon beta 1b?
MediHelp rates the interaction as major. Idecabtagene vicleucel and Interferon beta 1b can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Idecabtagene vicleucel is a CAR-T cell therapy that causes prolonged cytopenias and immune compromise. Interferon beta may add to immune and marrow effects and could influence CAR-T cell activity. The combined effect on infection risk and efficacy is not well characterized.
How serious is the interaction between Idecabtagene vicleucel and Interferon beta 1b?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid interferon beta around CAR-T infusion and consider alternative multiple sclerosis therapy. If it cannot be avoided, monitor blood counts and infection signs closely.
What other medicines interact with Interferon beta 1b?
MediHelp also lists interactions of Interferon beta 1b with, for example, Axicabtagene ciloleucel, Brexucabtagene autoleucel, Ciltacabtagene autoleucel. The full list is on the Interferon beta 1b page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
